AI Stocks To Watch As Productivity Becomes The New Market Focus

Central banks are keeping a close eye on inflation and growth, and many now highlight the role that productivity gains from technology could play in easing pressure. Artificial intelligence sits at the heart of that conversation. Investors are watching how AI stocks might benefit if businesses seek more efficient ways to work. This article looks at 3 AI stocks from the screener that stand out in this backdrop.

The 3 AI stocks covered below are only a sample of what the broader opportunity set looks like, with the full screen surfacing 14 more companies tied to semiconductors, enterprise software, LLMs, ChatGPT and cloud infrastructure that are not covered in this article. To see the rest, head straight to the Artificial Intelligence/ AI Stocks screener to identify, filter and analyze the ChatGPT and AI stocks that best fit your own conviction and risk profile.

Sponsored

Sponsored Insight

Put your message inside a calm, editorial reading experience.

Partner with us ->

Overview: Aura Consolidated Group (ASX:AXQ) provides a digital safety platform for consumers and employees, offering credit monitoring, identity theft protection and insurance, online data removal, VPN and privacy tools, antivirus and device security, password management and scam protection. The company also offers child online safety products such as parental controls, gaming and messaging insights, digital wellbeing scoring and AI based app monitoring, with operations in Australia and the United States.

Operations: Aura Consolidated Group generates about US$190 million in annual revenue, primarily from Security Software & Services in Australia.

Market Cap: A$722 million

Aura Consolidated Group is attracting attention because it sits at the intersection of cybersecurity, identity protection and AI driven child online safety, with revenue of about US$190 million and revenue growth of 31.3% over the past year. Forecasts point to earnings and revenue growth, and the stock currently trades at a P/S of 2.7x. This is in line with Australian software peers, while some estimates suggest a large discount to fair value. On the other hand, Aura is still loss making, has less than one year of cash runway and very limited trading liquidity, with a relatively new management team and board. For investors, the mix of rapid growth, fresh IPO funding and execution risk makes this a company that may warrant closer attention.

Rapid revenue growth with AI driven child safety tools is only half the Aura Consolidated Group story. To see how forecasts, cash runway and valuation line up, go through the analyst forecasts for Aura Consolidated Group

Build your own AI safety and security shortlist

Aura Consolidated Group and the other 2 AI stocks in this article all surfaced through a simple screener, and you can set up your own filters around valuation, growth, quality, risks and more. Use our flexible Screener to shape a watchlist that fits your approach, or jump straight into our curated Investing Ideas.

Overview: Xero (ASX:XRO) provides cloud based accounting, payroll, payments and tax software that helps small businesses and their advisors manage finances, automate routine tasks and stay on top of compliance from one online platform. It also offers connected tools such as employee scheduling, e invoicing, bill capture and AI supported reporting to deepen its role in day to day financial operations.

Operations: Xero generates about NZ$2.8b in revenue from providing online solutions for small businesses and their advisors, with key markets including Australia, the United Kingdom, the United States, New Zealand and the Rest of World.

Market Cap: A$13.3b

Xero gives you exposure to the shift toward cloud based, AI assisted finance tools for small businesses, backed by analyst forecasts of revenue growth of 16.5% a year and earnings growth of around 30.1% a year. The business reports gross margins near 88% and is weaving AI more deeply into its platform through features like JAX automation, Microsoft 365 and Anthropic integrations and AI powered analytics, which could make its software more embedded in customer workflows. At the same time, the stock trades on a very high P/E, profit margins are currently 6.1% and questions have been raised about management experience and incentive alignment. For investors, the mix of growth potential, AI product momentum and valuation and governance risks makes Xero a company worth closer study.

Xero’s AI push, high gross margins and premium P/E suggest something significant may be developing beneath the surface. Get the full story in the analysis report for Xero and see what might be hiding behind those early profit margins.

Overview: Echo IQ (ASX:EIQ) is an Australian health tech company that uses artificial intelligence to read echocardiogram data and flag patients at risk of structural heart disease, such as aortic stenosis, diastolic dysfunction and heart failure. Its EchoSolv platform is designed to support cardiologists and hospitals by turning complex heart imaging data into clearer risk scores that can guide earlier and more targeted treatment decisions.

Operations: Echo IQ currently generates about A$0.09 million in revenue from the development of artificial intelligence software.

Market Cap: A$1.2 billion

Echo IQ operates at the forefront of AI in healthcare, with a small current revenue base and an ambitious plan to make heart imaging more useful for doctors. The recent alliance with Mayo Clinic to test its platform in oncology patients, together with the appointment of a seasoned medtech CFO, provides Echo IQ with additional credibility in a complex clinical and regulatory environment. At the same time, revenue is still below US$1 million, losses are widening, analysts do not expect profitability within three years, and the P/B multiple is far above software peers, so expectations are already high. For investors looking at AI stocks, the combination of medical potential, early traction, and elevated funding and execution risk makes this a company that may warrant careful, ongoing research.

Echo IQ sits at the intersection of early stage revenue, high expectations and AI healthcare potential. See how the 2 key rewards and 3 important warning signs (1 is major!) could reframe the risk reward trade off and reveal what the market might be missing.

Seeking Alternatives Before The Crowd Moves

Fresh ideas move fast. By the time most investors react, the early entry window can be gone and momentum already flying. Scan these under the radar lists while it matters and consider them carefully.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com